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P.B. Licht,* T. Balezantis, B. Wolff, J.-F. Baudier and O.C. RøderDepartment of Cardiothoracic and Vascular Surgery, Southern Danish University,
Odense University Hospital, DenmarkObjectives. To evaluate short- and long-term mortality and morbidity in patients that were treated for acute upper
extremity ischemia.
Design. Single center retrospective study.
Patients. A consecutive series of 148 patients who were admitted with a diagnosis of acute ischemia of the upper extremity
during an 11-year period.
Methods. All charts were reviewed retrospectively and 96% of all survivors participated in clinical follow-up.
Results. The median age was 78 years and 64% of patients were females. The 30-day mortality was 8% and the overall
5-year survival 37%. The observed mortality during the follow-up period was significantly higher than expected. Survival
was not significantly different in patients who received anticoagulant drugs following discharge from the hospital. The
duration of ischemia did not significantly influence long-term arm-function.
Conclusions. Acute embolic episodes in the upper extremity primarily occur in elderly and the peri-operative mortality is
high. Mortality following discharge from the hospital remains significantly higher than that of the background population.Keywords: Upper extremity; Arterial occlusion; Embolectomy; Outcome.Introduction
Acute arterial occlusions in the upper extremity are
rare compared with the lower extremity.1 It is almost
always caused by an embolus and is best treated by
embolectomy with a balloon catheter as soon as
possible.1 Numerous follow-up studies have been
published regarding embolectomy in the lower extre-
mity. Few reports have focused on the upper extre-
mity2–9 and most of these only present short-term
outcome.2–6 It is well known that most emboli in the
upper extremity occur in elderly and peri-operative
mortality is high following embolectomy.1 However, it
is not clear whether mortality following discharge
from the hospital remains higher compared with the
background population. These findings prompted us
to initiate a clinical follow-up study to investigate both
short- and long-term mortality and morbidity in
patients who were treated for acute upper extremity
ischemia.ing author. Peter Bjørn Licht, Department of Cardi-
Vascular Surgey, Odense University Hospital, DK-
Denmark.
: licht@dadlnet.dk (P.B. Licht).
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‘Karbase’ is a national database which holds infor-
mation on patients who have been treated at Danish
departments of vascular surgery.10 We used this
database to identify patients who were admitted to
our department with a diagnosis of acute ischemia of
the upper extremity during an 11-year period (Sep-
tember 1991–December 2002). Arterial trauma, mainly
from cardiac catheterization, was not included
because we considered this an entirely different
patient population.
All hospital records were retrieved and the follow-
ing data recorded: (1) approximate time of symptom
onset (established to the nearest hour before surgery),
(2) medical history, (3) smoking habits, (4) medi-
cations, (5) findings at physical examination upon
admission, (6) operative findings, (7) post-operative
course and (8) medications at discharge from the
hospital.
In those patients who died during the follow-up
period (1991–2003) the various causes of death were
established from the official death-certificates that
were retrieved along with autopsy reports whenEur J Vasc Endovasc Surg 28, 508–512 (2004)
doi:10.1016/j.ejvs.2004.08.007, available online at http://www.sciencedirect.com onved.
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product limit method using the Kaplan–Meier pro-
cedure implemented in the SPSS 10.1 statistical soft-
ware package. Survival was calculated from the time
of surgery. The observed mortality during the follow-
up period was compared with the expected mortality
in a sex- and age-matched background population.
Firstly, the number of years that sex- and age-matched
patients would have lived through corresponding
calendar years was calculated. Secondly, for each
calendar-year, the number of accumulated patient-
years were multiplied with the corresponding mor-
tality rates, provided by the national service Danish
Statistics (www.dst.dk) giving the expected mortality.
Finally, the Score-test statistic SZ ðOKEÞ2=E was
calculated. This statistic tests the probability of equal
mortality between patients and the background
population and follows a Chi-square distribution
with one degree of freedom.11 P-values less than 0.05
were considered statistically significant.
All survivors, except two patients who were
amputated, were invited to participate in a clinical
follow up. One patient refused to participate but the
remaining (nZ68) were examined by the same
investigator with particular attention to pulse deficits,
motor power, and diminished sensation. The arm-
function was assessed by history and examination and
recorded as normal, slightly decreased or severely
decreased.Surgical technique
Once a diagnosis of acute arterial obstruction of the
upper extremity was made all patients underwent
immediate surgical exploration under local anaes-
thesia. An S-shaped incision was made in the
antecubital fossa for easy identification of the
brachial, radial and ulnar artery. A transverse
incision in the brachial artery was used and a
balloon catheter was introduced for selective
thrombo-embolectomy in each of the three vessels.
If the surgeon was not satisfied with the arterial
run-off intra-arterial thrombolysis was performed.
Before 1999 we used up to three bolus injections of
Streptokinase (25.000 units each) but after 1999 we
have used Actilysis (5–10 mg). If the surgeon
suspected thrombosis because of local arteriosclero-
sis as the main cause of acute ischemia the artery
was reconstructed with a vein patch. None of our
patients received heparin pre-operatively but all
received low molecular weight heparin post-opera-
tively (40 mg enoxaparin daily for 5 days).Results
We identified a total of 148 consecutive patients who
were admitted to our department with a diagnosis of
acute ischemia of the upper extremity. The median age
of our patients was 78 years (range 27–93) and 94
patients were females (64%). The diagnosis of acute
arterial occlusion in the upper extremity was made
solely on the patient history and a physical examin-
ation in 130 patients (88%). In the remaining 18
patients additional angiography was used in 17 and
one underwent ultrasound examination. The duration
of ischemia before surgery (from 147 available patient
charts) was less than 12 h in 72 patients (49%), between
12–24 h in 37 (25%), and more than 24 h in 38 patients
(26%). All patients presented with unilateral coldness
of the upper extremity without radial pulse and at
least one of the following: restpain (52%), paresthesia
(30%) or some degrees of paralysis (26%). The site of
the lesion was in the right upper extremity in 90
patients (61%). Nine patients suffered from diabetes
and 23 had a history of cerebral stroke. An embolus
originating from the heart was assumed to be the
reason for ischemia in 90 cases (61%), i.e. 75 patients
(51%) suffered from atrial fibrillation, nine patients
(6%) had valvular heart disease and six patients (4%)
had isolated ischemic heart disease. Local thrombosis
in the brachial artery was identified in four patients
(3%) one of whom also had a subclavian artery
aneurysm diagnosed at angiography. In the remaining
54 patients (37%) the etiology was unknown.
At the time of diagnosis 49 patients (33%) received
acetylisalicylic acid and eight patients (5%) were on
coumarins. Smoking habits were available from 108
patient charts (73%): Of these 60 patients were non-
smokers (56%), 38 were smokers (35%), and 10 were
previous smokers (9%).
A review of the patient charts did not allow us to
determine the exact anatomic site of the occlusion but
at the operation a thrombo-embolus was recovered in
all patients. Surgery consisted of simple embolectomy
with a balloon catheter in 138 patients (93%). In
addition five patients underwent embolectomy and
local reconstruction of the brachial artery and another
five patients received intra-operative intra-arterial
Streptokinase/Actilyse. The pulse was restored in
the radial artery in 133 patients (90%) and the in ulnar
artery in 85 patients (57%). According to the surgical
note a satisfactory result was achieved in 134 cases
(91%). Seven patients underwent re-embolectomy
during the hospital stay. Five of these had a successful
outcome but amputation was necessary in two. At the
time of discharge from the hospital 74 patients (50%)
were treated with acetylicsalicylic acid, 40 patientsEur J Vasc Endovasc Surg Vol 28, November 2004
Fig. 1. Kaplan–Meyer survival curve of all patients who were
admitted with acute ischemia of the upper extremity.
P. B. Licht et al.510(27%) received coumarin and five patients (3%)
received both.
The 30-day mortality was 9% (14 patients). Four
patients died from cardiovascular failure, four from
respiratory failure, three suffered a stroke, two had a
major gastrointestinal bleeding episode and one died
from tumour cachexia. During the follow-up period 77
patients (52%) died. The survival curve for all patients
is shown in Fig. 1. The overall 2-year survival was 64%,
3-year survival was 54% and 5-year survival was 37%.
We found no significant difference in survival between
patients who did or did not receive any of the two
methods of anticoagulation following discharge: Log-
rankZ0.27 (pZ0.61). Likewise, there was no signifi-
cant difference in survival when acetylisalicylic acid or
coumarins were analysed separately. Finally, we did
not discover any significant difference in survival
between patients who did or did not have a palpable
radial pulse post-operatively: logrankZ0.07 (pZ0.79).
Sixty-eight survivors participated in a follow-up
examination after a median follow-up time of 29
months (range 7–108). At follow-up the radial pulse
was palpable in 63 patients (93%) and the ulnar pulse
was palpable in 37 patients (54%). Fifty-seven patients
had a normal arm-function (84%). Nine patients (13%)
had a slightly decreased arm-function and two
patients (3%) a severely decreased arm-function. The
relationship between arm-function and duration ofTable 1. The relationship between arm-function and duration of isch
Armfunction
Normal
armfunction
Slightly decre
armfunction
Less than 12 h 33 (87%) 4 (11%)
12–24 h 13 (93%) 1 (7%)
More than 24 h 11 (69%) 4 (25%)
Total 57 (84%) 9 (13%)
Eur J Vasc Endovasc Surg Vol 28, November 2004ischemia is shown in Table 1. There was no significant
statistical difference between the three time intervals:
Chi-squareZ3.9 (pZ0.42). Similarly, there was no
statistically significant relationship between the arm-
function and presence of neurological deficits before
operation: Chi-squareZ4.22 (pZ0.12). One patient
underwent amputation of his second and fourth finger
post-operatively. Another patient had a post-operative
ischemic contracture of three fingers even though his
arm was revascularized before 12 h. Both patients had
a palpable radial pulse at follow-up
The 63 patients who died after 30 days were used
for comparison of the long-term observed and
expected mortality. The number of accumulated
patient years in a sex- and age-matched background
population multiplied with the corresponding death
rates resulted in an expected mortality of 23 patients.
Thus, SZ ðOKEÞ2=EZ76:7 (p!0.001) indicating a
significantly higher observed mortality. The best
estimate of increased mortality in our patients is
O/EZ2.8.11Discussion
Numerous studies of acute arterial occlusion in the
lower extremity have been carried out but long-term
follow-up studies are limited in the upper extremities.
In an excellent review of the literature Eyers and
Earnshaw found that acute arm ischemia accounts for
a mean of 17% (7–32%) of cases of acute ischemia of the
limbs.1 Our study confirms that acute upper extremity
ischemia due to emboli is rare accounting for 1% of all
admissions or 7% of all acute admissions to our
department during the study period.
Most studies attribute the cause of embolism to
associated cardiac conditions but often they cannot be
confirmed pathologically.1 The majority use the
following criteria for embolism: sudden clinical
presentation, absence of peripheral arteriosclerosis
and removal of discrete ‘clot’ at operation. Our study
demonstrates that the diagnosis is relatively easy
based on patient history and clinical findings alone
in 88%. Arteriography was rarely needed in agreement
with most previous reports.emia (147 available patient charts)
Total
ased Severely decreased
armfunction
1 (2%) 38
14
1 (6%) 16
2 (3%) 68
Table 2. The cause of death in the 77 patients who died during the
follow-up period
N
Cardiovascular 25 (32)
Cerebrovascular 17 (22%)
Respiratory 10 (13%)
Gastrointestinal bleeding 3 (4%)
Ruptured AAA 2 (3%)
Malignancy 6 (8%)
Intestinal ischemia 2 (3%)
Renal insufficiency 1 (1%)
Pulmonary emboli 1 (1%)
Suicide 1 (1%)
Unknown 9 (12%)
Total 77 (100%)
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prompt operative intervention is the single most
important determinant of a successful outcome. In a
study of patients with arterial embolization Abbott
found that patients whose treatment began less than
12 h after onset had a higher limb salvage and a lower
mortality when compared with patients whose treat-
ment began after more than 12 h.12 Similarly, in
patients who suffered from arterial embolization in
general, mainly in the lower extremity, Elliot found
that within the range of 8 h to 7 days the effect of
delayed treatment had a linear relationship to severity
of ischemic changes and unfavourable results.13 In
contrast, some reports claim that the duration of the
symptoms before embolectomy in general does not
have a significant effect on the mortality,14,15 and one
study which focused on the upper extremity reported
that late embolectomy was successful.7 In our depart-
ment we always operate on patients acutely to
minimise the duration of ischemia and, thus, the risk
of compromised arm function. Nevertheless 26% of
our patients were treated more than 24 h after the
onset of symptoms and, at least among the survivors,
the time interval between symptom onset and revas-
cularization did not significantly influence the long-
term result as measured by arm-function. Only two of
the surviving patients suffered from severely reduced
arm-function. One was revascularized before 12 h and
the other after 24 h. Thus, we believe that the time
interval per se is not a contraindication for surgery and
we only consider the extremity out of therapeutic
reach if the patient presents with a rigid limb
indicating irreversible ischemia. Such limbs were not
encountered in the upper extremity during the study
period. It may be argued that analysis of the length of
ischaemia and arm function does not take into account
the severity of ischaemia. Thus, patients who pre-
sented after 24 h may have had less severe arm
ischaemia than those who presented earlier because
of the pain. However, one would expect that patients
with severe ischaemia presented with neurological
deficits and our study fail to detect any statistically
significant difference in arm function between patients
who did or did not have neurological deficits before
surgery.
Acute embolic episodes in the upper extremity
predominantly occur in the elderly.1 The median age
of our patients was 78 years. It is well known that early
mortality is high in these patients and that older
patients have a higher mortality.15–17 Despite a
seemingly small surgical procedure under local
anaesthesia the 30-day mortality in our study was
9%. Previous studies in the upper extremity have
reported a 30-day mortality up to 19% followingembolectomy.5 As demonstrated in Table 2 the most
common causes of death in our patients were
cardiovascular or cerebrovascular events.1 In addition
to the high peri-operative mortality our results
demonstrate that patients continue to have a higher
mortality compared with the background population
following discharge from the hospital. The observed
mortality was 2.8 times higher than expected. While
several papers on arterial embolization in general,
predominately in the lower extremity, have demon-
strated an increased long-term mortality,13,18 it
appears that this is the first study focussing on the
upper extremity which demonstrates an increased
long-term mortality.
The peri- and post-operative mortality of patients
undergoing embolectomy in general may be reduced
by anticoagulant treatment 13,16,19 and it appears that
the long-term functional results may also be improved
by anticoagulants.13,16 Only 50, 27 and 3% of our
patients were discharged with acetylisalicylic acid,
coumarins, or both, respectively, a practice we have
changed. In the last 2 years all patients were
discharged with acetylisalicylic acid and those who
suffered from atrial fibrillation also received cou-
marins. Nevertheless, our results fail to demonstrate
any significant difference in survival between patients
who did or did not receive anticoagulants. This
finding contrasts with results from another report
which focused on the upper extremity.19 We have no
obvious explanation for it. Theoretically, it could be a
consequence of low compliance in patients who
received anticoagulants but we believe this is unlikely.
Failure to restore the radial pulse has been regarded
as a strong indicator of poor outcome.20 Our results fail
to confirm this finding as there was no significant
difference in survival between patients who did or did
not have the radial pulse restored at the operation. One
possible explanation may be found in a literature
review which states that occlusion of a major artery in
the upper extremity is better tolerated than it is in theEur J Vasc Endovasc Surg Vol 28, November 2004
P. B. Licht et al.512lower limb, possibly because the potential for the
development of a collateral circulation is better, but
also because the bulk and work rate of the muscles of
the arm are considerably less than those of the leg.5References
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